
Loading, please wait...

Loading, please wait...

Fluorine atoms significantly enhance the metabolic stability and bioavailability of modern pharmaceuticals. **Consequently**, the **deoxyfluorination of alcohols** has become a cornerstone of medicinal chemistry. This process allows scientists to replace hydroxyl groups with fluorine. **Specifically**, it creates molecules that are more resistant to enzymatic breakdown. **Recently**, researchers introduced a groundbreaking strategy using sulfonium salts to streamline this essential transformation. **Because** of this advancement, chemists can now access fluorinated compounds more efficiently than ever before.
The newly developed strategy utilizes sulfonium salts to mediate the reaction under mild and rapid conditions. **In contrast** to traditional methods, this approach does not require preactivation of the substrate. **Furthermore**, it demonstrates impressive versatility across primary, secondary, and tertiary alcohols. **In addition**, this innovation simplifies the production of fluorinated compounds. **Moreover**, because the reaction maintains exceptional functional group tolerance, it effectively modifies complex natural molecules. **As a result**, developers can utilize this method for late-stage modifications of delicate drug candidates.
DFT calculations and control experiments have clarified the crucial role of the sulfonium salt in the reaction pathway. **Notably**, the salt acts as a bridge that facilitates the transition from a common alcohol to a precise fluoride. **Thus**, this strategy provides a robust tool for late-stage functionalization. **Furthermore**, it allows chemists to fluorine-block metabolic soft spots in drug candidates. **Therefore**, this methodology promises to accelerate the discovery of safer and more effective therapeutic agents.
It allows for the strategic introduction of fluorine, which improves a drug's lipophilicity, metabolic stability, and binding affinity to target receptors.
This method works under mild conditions without preactivation, making it highly efficient for complex molecules and a wide range of alcohol types.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new sulfonium salt-mediated strategy allows for rapid, mild deoxyfluorination of alcohols, improving the synthesis of complex fluorinated drug molecules....
5 months ago

Following the admission of Union Health Minister JP Nadda to AIIMS Delhi for acute uneasiness, clinical teams utilized diagnostic coronary angiography and inpatient observation. This clinical review outlines acute triage pathways, procedural protocols, post-procedure observation, and long-term risk management.
Today

A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Yesterday

India faces an acute deficit in deceased organ procurement despite rising transplant numbers. With nearly 90,000 patients waiting and deceased donations contributing only 18% of total transplants, healthcare professionals must actively dispel brain death misconceptions and streamline retrieval systems to save lives.
Today

Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today

Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today